Harmine Plus Exendin-4 Enhances Remission of Recent-Onset Type 1 Diabetes Following Anti-CD3 Therapy
- DOI
- 10.64898/2026.09.21.753317
- Published
- 2026-09-22
- Container
- Not recorded
- Publisher
- openRxiv
- Open access
- unknown
Credibility signals
uncertain Score 60/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- cautionPublication version: Identified as a preprint; peer review and later versions may change the record.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.64898/2026.09.21.753317,
title = {Harmine Plus Exendin-4 Enhances Remission of Recent-Onset Type 1 Diabetes Following Anti-CD3 Therapy},
author = {Geming Lu and Randy Kang and Miguel Varela and Eunjin Oh and Yansui Li and Jungeun Lee and Leah Kebrom and Juan Aldaco and Jiamin Zhang and Madeline Wichman and Mingpei Li and Fouad Kandeel and Meirigeng Qi and Peng Wang and Robert J. DeVita and Alberto Pugliese and Debbie C. Thurmond and Andrew F. Stewart and Adolfo Garcia-Ocana},
year = {2026},
doi = {10.64898/2026.09.21.753317},
url = {https://doi.org/10.64898/2026.09.21.753317}
}RIS
TY - JOUR TI - Harmine Plus Exendin-4 Enhances Remission of Recent-Onset Type 1 Diabetes Following Anti-CD3 Therapy AU - Geming Lu AU - Randy Kang AU - Miguel Varela AU - Eunjin Oh AU - Yansui Li AU - Jungeun Lee AU - Leah Kebrom AU - Juan Aldaco AU - Jiamin Zhang AU - Madeline Wichman AU - Mingpei Li AU - Fouad Kandeel AU - Meirigeng Qi AU - Peng Wang AU - Robert J. DeVita AU - Alberto Pugliese AU - Debbie C. Thurmond AU - Andrew F. Stewart AU - Adolfo Garcia-Ocana PY - 2026 DO - 10.64898/2026.09.21.753317 UR - https://doi.org/10.64898/2026.09.21.753317 ER -
APA
Lu, G., Kang, R., Varela, M., Oh, E., Li, Y., Lee, J., Kebrom, L., Aldaco, J., Zhang, J., Wichman, M., Li, M., Kandeel, F., Qi, M., Wang, P., DeVita, R. J., Pugliese, A., Thurmond, D. C., Stewart, A. F., & Garcia-Ocana, A. (2026). Harmine Plus Exendin-4 Enhances Remission of Recent-Onset Type 1 Diabetes Following Anti-CD3 Therapy. https://doi.org/10.64898/2026.09.21.753317
Source records
- crossref · retrieved 2026-11-08T15:42:02.004Z